Workflow
Itron to Announce Third Quarter Results on October 30, 2025
Globenewswire· 2025-10-09 20:05
LIBERTY LAKE, Wash., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Itron, Inc. (NASDAQ: ITRI), which is innovating new ways for utilities and cities to manage energy and water, announced today that it will release financial results for the quarter ended Sept. 30, 2025 before the market opens on Thursday, Oct. 30, 2025. The company’s press release and financial statements will be available on the company’s website at https://investors.itron.com on Oct. 30, 2025 at 8:30 a.m. EDT followed by the management conference call ...
Tenaya Therapeutics to Participate in H.C. Wainwright Genetic Medicines Virtual Conference
Globenewswire· 2025-10-09 20:05
SOUTH SAN FRANCISCO, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that Faraz Ali, Tenaya’s Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright Genetic Medicines Virtual Conference on Tuesday, October 14, 2025. Company management will host virtual 1x1 mee ...
Resmed to Report First Quarter Fiscal 2026 Earnings on October 30, 2025
Globenewswire· 2025-10-09 20:05
Core Viewpoint - Resmed plans to release its financial and operational results for Q1 of fiscal year 2026 on October 30, 2025, after market close, followed by a management webcast to discuss the results and other relevant information [1]. Group 1: Earnings Release Details - The earnings release will occur on October 30, 2025, after the New York Stock Exchange closes [1]. - A webcast will be hosted by Resmed management to discuss the results and other forward-looking information [1]. - A replay of the earnings webcast will be available on Resmed's investor relations website approximately two hours after the live event [2]. Group 2: Company Overview - Resmed is dedicated to creating innovative health technologies aimed at improving the quality of life for individuals in 140 countries [2]. - The company focuses on AI-powered digital health solutions, cloud-connected devices, and intelligent software to enhance home healthcare [2]. - Resmed envisions a future where individuals can achieve better sleep and breathing through personalized care delivered at home [2].
Paylocity announces Q1 FY26 earnings conference call
Globenewswire· 2025-10-09 20:05
SCHAUMBURG, Ill., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Paylocity Holding Corporation (Nasdaq: PCTY), a leading provider of cloud-based HR, Finance, and IT solutions, today announced that it has scheduled a conference call to review its first quarter fiscal 2026 results on Tuesday, November 4th at 4:00 pm Central Time (5:00 pm Eastern Time). A live webcast of the call will be available on the “Investor Relations” page of the Company’s website at https://investors.paylocity.com/. To access the call by phone, ple ...
AirJoule Technologies Applauds 2025 Nobel Prize in Chemistry Winners for Foundational Work on Metal-Organic Frameworks
Globenewswire· 2025-10-09 20:05
AirJoule Technologies is Leading the Commercial Deployment of MOF Technology for Extracting Pure Distilled Water from AirRONAN, Mont., Oct. 09, 2025 (GLOBE NEWSWIRE) -- AirJoule Technologies Corporation (NASDAQ: AIRJ) (“AirJoule Technologies” or the “Company”), a leading technology platform that unleashes the power of water from air, congratulates Susumu Kitagawa, Richard Robson, and Omar Yaghi on their receipt of the 2025 Nobel Prize in Chemistry for developing metal-organic frameworks ("MOFs"). This prest ...
Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Globenewswire· 2025-10-09 20:05
REDWOOD CITY, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (NASDAQ: RZLT), (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today announced that it has granted as of September 30, 2025 equity inducement awards to two new employees. The equity awards were approved by the Compensation Committee of the Company’s Board of Directors in accordance with Nasdaq Listing Rule 5635(c)(4) and were made as a material inducement to th ...
Mondelēz International to Report Q3 2025 Financial Results on October 28, 2025
Globenewswire· 2025-10-09 20:05
Core Viewpoint - Mondelēz International, Inc. is set to release its third quarter 2025 financial results on October 28, 2025, followed by a conference call for investors and analysts [1]. Company Information - Mondelēz International operates in over 150 countries and reported net revenues of approximately $36.4 billion in 2024 [4]. - The company is recognized for its iconic brands, including Oreo, Ritz, LU, Clif Bar, Tate's Bake Shop, Cadbury Dairy Milk, Milka, and Toblerone [4]. - Mondelēz International is a member of the Dow Jones Best-in-Class North America and World Indices, previously known as the Dow Jones Sustainability Indices [4]. Conference Call Details - The conference call will take place on October 28, 2025, at 5:00 p.m. ET, with a phone participation option available for investors and analysts [2]. - A replay of the conference call will be accessible until November 04, 2025, with specific access codes provided for both the live call and the rebroadcast [3].
Procedure of the Annual General Meeting
Globenewswire· 2025-10-09 20:01
ANNOUNCEMENT NO. 294 9 October 2025 Procedure of the Annual General Meeting The Annual General Meeting of ChemoMetec A/S was held on 9 October 2025 at 5.30 p.m. at Nordsjællands KonferenceCenter. At the Annual General Meeting, the Board of Directors' report on the company's activities during the past year was presented, the annual report for 2024/25 was approved, and the Board of Directors and the Executive Board were granted discharge. The Annual General Meeting approved the proposal of the Board of Dire ...
Sunrise Achieves Key Process Breakthrough in Solid-State Battery Anode Material Technology
Globenewswire· 2025-10-09 19:30
Core Insights - Sunrise New Energy Co., Ltd. has announced a significant technological breakthrough by co-developing an industry-leading CVD fluidized bed system for silicon-carbon anodes in collaboration with Songci Electromechanical Technology Co., Ltd. This marks a milestone in the industrialization of silicon-carbon anode materials and supports the commercialization of solid-state batteries [1][3]. Group 1: Technological Development - The collaboration combines Sunrise's expertise in silicon-carbon anode materials with Songci Electromechanical's manufacturing capabilities, resulting in a CVD fluidized bed system that features high deposition and coating uniformity, precise temperature and concentration control, and AI-enabled intelligent management [2][4]. - The new system addresses challenges of uniformity and consistency in traditional CVD processes, significantly enhancing product performance in energy density, first-cycle efficiency, and cycling stability, which is crucial for large-scale applications in solid-state and high-energy-density energy storage batteries [3][4]. Group 2: Strategic Collaboration - The partnership between Sunrise and Songci Electromechanical represents a deep integration of expertise across materials and equipment, establishing a collaborative innovation model that connects material development, equipment design, and industrial-scale implementation [4]. - Sunrise aims to deepen its collaboration with industry partners to further accelerate the industrialization of silicon-carbon anode materials, focusing on building an integrated ecosystem that spans materials, equipment, and applications to enhance the efficiency and sustainability of the global new energy industry [5]. Group 3: Company Overview - Sunrise New Energy Co., Ltd. is headquartered in Zibo, Shandong Province, China, and is engaged in the manufacturing and sale of graphite anode material for lithium-ion batteries. The company has a manufacturing facility in Guizhou Province with a production capacity of 50,000 tons, utilizing inexpensive renewable electricity to minimize environmental impact [6]. - The founder and CEO, Mr. Haiping Hu, is recognized as a pioneer in the graphite anode industry in China, and the management team consists of experts with extensive experience and successful track records in the field [6].
Bluejay Diagnostics Announces $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules
Globenewswire· 2025-10-09 19:15
Core Viewpoint - Bluejay Diagnostics, Inc. has announced a private placement of common stock and Series F warrants to raise approximately $4.5 million to fund FDA approval processes and other R&D activities [1][2]. Group 1: Offering Details - The company will sell 2,250,000 shares of common stock at a price of $2.00 per share, along with Series F warrants to purchase up to 4,500,000 additional shares at an exercise price of $1.75 [1]. - The Series F warrants will be exercisable immediately and will expire 5.5 years from the issuance date [1]. - The private placement is expected to close on or about October 10, 2025, pending customary closing conditions [1]. Group 2: Use of Proceeds - The net proceeds from the offering will be used for obtaining FDA approval, including related clinical studies, as well as for general working capital and other research and development activities [2]. Group 3: Company Overview - Bluejay Diagnostics focuses on improving patient outcomes with its Symphony System, a rapid near-patient testing system for sepsis triage and disease monitoring [5]. - The company's first product candidate is an IL-6 Test for sepsis, designed to deliver results in approximately 20 minutes, aiding medical professionals in making timely treatment decisions [5].